These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
526 related articles for article (PubMed ID: 23618965)
1. Functional alginate nanoparticles for efficient intracellular release of doxorubicin and hepatoma carcinoma cell targeting therapy. Guo H; Lai Q; Wang W; Wu Y; Zhang C; Liu Y; Yuan Z Int J Pharm; 2013 Jul; 451(1-2):1-11. PubMed ID: 23618965 [TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy. Zhang C; Wang W; Liu T; Wu Y; Guo H; Wang P; Tian Q; Wang Y; Yuan Z Biomaterials; 2012 Mar; 33(7):2187-96. PubMed ID: 22169820 [TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy. Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860 [TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin. Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765 [TBL] [Abstract][Full Text] [Related]
5. Folate mediated self-assembled phytosterol-alginate nanoparticles for targeted intracellular anticancer drug delivery. Wang J; Wang M; Zheng M; Guo Q; Wang Y; Wang H; Xie X; Huang F; Gong R Colloids Surf B Biointerfaces; 2015 May; 129():63-70. PubMed ID: 25829128 [TBL] [Abstract][Full Text] [Related]
6. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance. Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731 [TBL] [Abstract][Full Text] [Related]
7. Galactosylated gelatin nanovectors of doxorubicin inhibit cell proliferation and induce apoptosis in hepatocarcinoma cells. Garg M; Madan J; Pandey RS; Sardana S; Katyal A; Chandra R Anticancer Drugs; 2012 Sep; 23(8):836-45. PubMed ID: 22407250 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antitumor activity of doxorubicin-loaded alginic-acid-based nanoparticles. Cheng Y; Yu S; Wang J; Qian H; Wu W; Jiang X Macromol Biosci; 2012 Oct; 12(10):1326-35. PubMed ID: 22887841 [TBL] [Abstract][Full Text] [Related]
9. Efficacious hepatoma-targeted nanomedicine self-assembled from galactopeptide and doxorubicin driven by two-stage physical interactions. Ding J; Xiao C; Li Y; Cheng Y; Wang N; He C; Zhuang X; Zhu X; Chen X J Control Release; 2013 Aug; 169(3):193-203. PubMed ID: 23247039 [TBL] [Abstract][Full Text] [Related]
10. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin. Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461 [TBL] [Abstract][Full Text] [Related]
11. Redox- and light-responsive alginate nanoparticles as effective drug carriers for combinational anticancer therapy. Zhang C; Shi G; Zhang J; Niu J; Huang P; Wang Z; Wang Y; Wang W; Li C; Kong D Nanoscale; 2017 Mar; 9(9):3304-3314. PubMed ID: 28225139 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of drug loaded glycyrrhetinic acid modified alginate nanoparticles on mice bearing orthotopic liver tumor. Zhang C; Wu Y; Liu T; Zhao Y; Wang X; Wang W; Yuan Z J Control Release; 2011 Nov; 152 Suppl 1():e111-3. PubMed ID: 22195787 [No Abstract] [Full Text] [Related]
13. Liver cancer targeting of Doxorubicin with reduced distribution to the heart using hematoporphyrin-modified albumin nanoparticles in rats. Chang JE; Shim WS; Yang SG; Kwak EY; Chong S; Kim DD; Chung SJ; Shim CK Pharm Res; 2012 Mar; 29(3):795-805. PubMed ID: 21971829 [TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-loaded poly (lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications. Chai F; Sun L; He X; Li J; Liu Y; Xiong F; Ge L; Webster TJ; Zheng C Int J Nanomedicine; 2017; 12():1791-1802. PubMed ID: 28424550 [TBL] [Abstract][Full Text] [Related]
15. Co-delivery of glycyrrhizin and doxorubicin by alginate nanogel particles attenuates the activation of macrophage and enhances the therapeutic efficacy for hepatocellular carcinoma. Wang QS; Gao LN; Zhu XN; Zhang Y; Zhang CN; Xu D; Cui YL Theranostics; 2019; 9(21):6239-6255. PubMed ID: 31534548 [TBL] [Abstract][Full Text] [Related]
16. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
17. Formulation and cytotoxicity of doxorubicin loaded in self-assembled bio-polyelectrolyte microshells. Tao X; Chen H; Sun XJ; Chen JF; Roa WH Int J Pharm; 2007 May; 336(2):376-81. PubMed ID: 17223293 [TBL] [Abstract][Full Text] [Related]
18. Antitumor efficacy of doxorubicin-loaded laponite/alginate hybrid hydrogels. Gonçalves M; Figueira P; Maciel D; Rodrigues J; Shi X; Tomás H; Li Y Macromol Biosci; 2014 Jan; 14(1):110-20. PubMed ID: 23966317 [TBL] [Abstract][Full Text] [Related]
19. Glyco-nanoparticles with sheddable saccharide shells: a unique and potent platform for hepatoma-targeting delivery of anticancer drugs. Chen W; Zou Y; Meng F; Cheng R; Deng C; Feijen J; Zhong Z Biomacromolecules; 2014 Mar; 15(3):900-7. PubMed ID: 24460130 [TBL] [Abstract][Full Text] [Related]
20. Immobilization of coacervate microcapsules in multilayer sodium alginate beads for efficient oral anticancer drug delivery. Feng C; Song R; Sun G; Kong M; Bao Z; Li Y; Cheng X; Cha D; Park H; Chen X Biomacromolecules; 2014 Mar; 15(3):985-96. PubMed ID: 24502683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]